Pliant Therapeutics, Inc. Common Stock (PLRX) is a publicly traded Healthcare sector company. As of September 23, 2026, PLRX trades at $1.18 with a market cap of $68.73M and a P/E ratio of -0.47. PLRX moved +3.42% today. Year to date, PLRX is -6.56%; over the trailing twelve months it is -24.00%. Its 52-week range spans $1.02 to $12.88. Analyst consensus is neutral with an average price target of $2.50. Rallies surfaces PLRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks PLRX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.18 |
| Market Cap | $68.73M |
| P/E Ratio | -0.47 |
| EPS | $-2.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.88 |
| 52-Week Low | $1.02 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-149.34M |
| Gross Margin | 0.00% |
5 analysts cover PLRX: 0 strong buy, 0 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.50.